Approvals/TGA/APX-LAMOTRIGINE lamotrigine 50 mg dispersible/chewable tablet blister pack

Approved

STANDARD

APX-LAMOTRIGINE lamotrigine 50 mg dispersible/chewable tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: df6706bc64d5d904
Product Name: APX-LAMOTRIGINE lamotrigine 50 mg dispersible/chewable tablet blister pack
Artg Id: 340908
Artg Name: APX-LAMOTRIGINE lamotrigine 50 mg dispersible/chewable tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2020-08-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/fab8392715964117e4debe006985e49f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/c4a1d4b473805bcdfbac88f5a223541f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

df6706bc64d5d904

Type

Standard